Welcome to our dedicated page for Astrotech news (Ticker: ASTC), a resource for investors and traders seeking the latest updates and insights on Astrotech stock.
Astrotech Corporation develops instrumentation businesses built around mass spectrometry and gas chromatography technologies through wholly owned subsidiaries. News about ASTC commonly covers 1st Detect and its TRACER 1000 trace detection systems for aviation security, explosives screening, and narcotics detection, including regulatory certifications, deployments, and security-market applications.
Company updates also address AgLAB process analyzers for agriculture products, Pro-Control industrial chemical process control, BreathTech breath-analysis work for volatile organic compounds, and EN-SCAN portable environmental GC-MS for field testing of air, water, and soil. Recurring releases include fiscal results, research and development progress, sales activity, leadership appointments, and board-level strategic or governance actions.
Astrotech (Nasdaq: ASTC) has expanded its Board of Directors from five to six members and appointed Matt Kreps as a new director. According to the company, Kreps adds extensive capital markets and investor relations experience from roles at HydroGraph Clean Power, Darrow Associates, Shelton Group, Magnolia Investor Relations, and Halliburton.
Kreps holds an Executive MBA in Global Leadership from the University of Texas at Dallas and a BS in Mass Communications from Kansas State University. Astrotech’s leadership expects his background and institutional investor relationships to support its strategy in lunar resource development and the mass-spectrometry industry.
Astrotech (Nasdaq: ASTC) submitted a proposal to NASA’s Commercial Lunar Payload Services 2 (CLPS2) program. The Phase 1 proposal seeks about $20 million in non-dilutive funding for lunar mining and materials-processing technology demonstrations.
The initiative supports Astrotech’s long-term lunar industrial strategy, leveraging its prior Shuttle-era spaceflight heritage.
Astrotech (Nasdaq: ASTC) approved a potential sale process for subsidiary 1st Detect, developer of the TRACER 1000 mass spectrometry explosives and narcotics trace detector. The company is considering a sale to fund its lunar mining initiative and leverage recent regulatory milestones.
The TRACER 1000 is described as the only certified, field-deployed mass spectrometry ETD, with TSA Air Cargo approval, ECAC passenger and cargo certifications (including G1 and wand swabbing), a DHS development award, and entry into the TSA checkpoint certification process.
Astrotech (Nasdaq: ASTC) announced that its 1st Detect TRACER 1000 has received ECAC certification for wand swabbing, approved for screening passengers and cargo in aviation security.
The system meets ECAC Explosives Detection Standard and Standard G1 and is deployed in 16 countries for no-touch molecular identification.
Astrotech (NASDAQ: ASTC) announced that its Board approved a strategic lunar resource and infrastructure initiative targeting future Moon-based semiconductor and quantum computing manufacturing.
The initiative covers silicon-28, helium-3, platinum group metals, and water ice, and aims to explore autonomous lunar industrial systems leveraging Astrotech’s spaceflight heritage and NASA Artemis-related opportunities.
Astrotech (NASDAQ: ASTC) subsidiary EN-SCAN launched the Labrador HH-GC, a rugged, field-portable gas chromatograph for on-site VOC analysis in air, water, and soil. The system targets environmental consulting, remediation, industrial hygiene, and regulatory response.
It offers ppb-level detection, results in about three minutes based on internal tests, multi-matrix capability, training and service support, and a one-year warranty. The instrument is available immediately for evaluation and deployment.
Astrotech (Nasdaq: ASTC) reported results for the third quarter of fiscal 2026, ended March 31, 2026. Research and development expense was $554 thousand, described as a 28% decline as the company transitions from development to saleable EN-SCAN Handheld GC and 1st Detect TRACER 1000 products.
Through March 31, 2026, the TRACER 1000 trace detection system had been deployed in about 37 locations across 16 countries in the United States, Europe and Asia, supporting commercialization efforts and customer engagement in industrial, safety and trace detection markets.
Astrotech (Nasdaq: ASTC) announced that its 1st Detect TRACER 1000 has received ECAC/EU G1 approval, meeting the highest European standards for aviation trace detection security.
The mass spectrometry-based system is field proven, with deployments in 16 countries, and includes an expandable threat library to address evolving security risks.
Astrotech (Nasdaq: ASTC) reported second-quarter fiscal 2026 results for the period ended December 31, 2025. R&D expense fell to $1,832 thousand, a 25% decline year-over-year as the company shifts from development to saleable products for EN-SCAN Handheld GC and TRACER 1000 lines.
Through Dec. 31, 2025, the company deployed the TRACER 1000 in approximately 35 locations across 16 countries. Management named Scott Bartley Interim CFO and David Spada Director of Global Sales.
Astrotech (Nasdaq: ASTC) announced on Jan 21, 2026 that subsidiary 1st Detect appointed industry veteran David Spada as Director of Global Sales to expand deployment of the TRACER 1000™ mass spectrometry trace detector in international security markets.
Spada brings over a decade of trace-detection experience from Implant Sciences, Morpho Detection, and Rapiscan Systems and previously led trace-detection sales and strategy for the Americas. The hire aims to accelerate commercial adoption of laboratory-grade, field-deployable molecular identification to reduce false alarms and strengthen screening checkpoints.